Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

SELL
$1.05 - $1.63 $23,625 - $36,675
-22,500 Reduced 45.45%
27,000 $30,000
Q1 2023

May 12, 2023

SELL
$1.2 - $2.73 $12,600 - $28,665
-10,500 Reduced 17.5%
49,500 $66,000
Q4 2022

Feb 13, 2023

SELL
$1.71 - $3.61 $13,680 - $28,880
-8,000 Reduced 11.76%
60,000 $111,000
Q3 2022

Nov 10, 2022

SELL
$1.9 - $8.63 $72,200 - $327,940
-38,000 Reduced 35.85%
68,000 $167,000
Q2 2022

Aug 12, 2022

SELL
$2.13 - $9.01 $4,260 - $18,020
-2,000 Reduced 1.85%
106,000 $259,000
Q1 2022

May 13, 2022

BUY
$6.28 - $15.59 $50,240 - $124,720
8,000 Added 8.0%
108,000 $861,000
Q4 2021

Feb 11, 2022

BUY
$14.7 - $28.67 $514,500 - $1 Million
35,000 Added 53.85%
100,000 $1.53 Million
Q3 2021

Nov 12, 2021

SELL
$24.31 - $33.6 $72,930 - $100,800
-3,000 Reduced 4.41%
65,000 $1.85 Million
Q1 2021

May 14, 2021

SELL
$33.06 - $56.93 $710,790 - $1.22 Million
-21,500 Reduced 24.02%
68,000 $2.6 Million
Q4 2020

Feb 05, 2021

SELL
$39.09 - $57.4 $58,635 - $86,100
-1,500 Reduced 1.65%
89,500 $3.74 Million
Q3 2020

Nov 06, 2020

SELL
$28.43 - $44.67 $426,450 - $670,050
-15,000 Reduced 14.15%
91,000 $3.95 Million
Q2 2020

Aug 13, 2020

BUY
$11.71 - $30.29 $23,420 - $60,580
2,000 Added 1.92%
106,000 $3.21 Million
Q1 2020

May 14, 2020

BUY
$7.64 - $27.5 $30,560 - $110,000
4,000 Added 4.0%
104,000 $1.42 Million
Q4 2019

Feb 14, 2020

BUY
$15.02 - $20.57 $60,080 - $82,280
4,000 Added 4.17%
100,000 $1.61 Million
Q2 2019

Aug 02, 2019

SELL
$17.37 - $26.27 $86,850 - $131,350
-5,000 Reduced 4.95%
96,000 $2.26 Million
Q1 2019

May 02, 2019

SELL
$10.65 - $25.75 $713,550 - $1.73 Million
-67,000 Reduced 39.88%
101,000 $2.37 Million
Q3 2018

Nov 02, 2018

SELL
$7.54 - $18.31 $135,720 - $329,580
-18,000 Reduced 9.68%
168,000 $2.81 Million
Q2 2018

Aug 10, 2018

SELL
$4.87 - $8.42 $19,480 - $33,680
-4,000 Reduced 2.11%
186,000 $1.37 Million
Q1 2018

May 09, 2018

BUY
$4.69 - $10.05 $211,050 - $452,250
45,000 Added 31.03%
190,000 $891,000
Q4 2017

Feb 02, 2018

BUY
$7.86 - $9.99 $196,500 - $249,750
25,000 Added 20.83%
145,000 $1.32 Million
Q3 2017

Nov 01, 2017

BUY
$8.89 - $10.4 $1.07 Million - $1.25 Million
120,000
120,000 $1.12 Million

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track Mario Gabelli's Portfolio

Track Mario Gabelli Portfolio

Follow Mario Gabelli (Gamco Investors, Inc. Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.